Perceptive LIFE Sciences Master FUND Ltd., 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), bought 315,030 shares at $22.22 ($7.0M) on 2022-04-18, disclosed to the SEC on 2022-04-18.
Recurring purchase ($7.0M) by 10% Owner following this insider's established cadence. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.22 | 157,515 | $3.5M | 50.0% |
| 2 | $22.22 | 157,515 | $3.5M | 50.0% |
| Total | $22.22 avg | 315,030 | $7.0M | 100% |
| Filing → |
| ACRV | BUY | 2024-04-15 | $20.0M | — | Filing → |
| ALDX | BUY | 2024-04-03 | $3.8M | — | Filing → |
| ALDX | SELL | 2023-10-18 | $5.0M | — | Filing → |